Topics currently receiving attention in the FDA News include:
- Transitioning to electronic labelling for instructions for use on medications, encouraging companies to go green and reduce paper costs and wastes when producing medication packaging.
- Oxycodone, an opioid pain reliever, is in shortage due to recalls and production delays.
These news stories could affect market share as follows:
Electronic labelling, if it becomes a standard in the enormous pharmaceutical industry, could greatly increase market share for software that would be label-compatible, both for end-users and manufacturers.
Oxycodone alternative pain relievers could experience an increase in sales and market share.
Do you share the concern about prescription drugs entering the market from offshore manufacturers that are able to circumvent FDA regulation?
ReplyDeleteI have so many concerns about unregulated Rx meds, I don't know where to start! The FDA is in my opinion barely able to keep up with safety standards for medications. If the meds are not even passing through those limited regulatory channels...ouch.
ReplyDelete